FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies Influencers are Lying About the FDA and Peptides This is the Truth (May 2026) This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides